Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
USDC faces bank-rate pressure – Can Visa’s payments push offset it?

USDC faces bank-rate pressure – Can Visa’s payments push offset it?

AMBCryptoAMBCrypto2026/10/19 00:03
By:AMBCrypto

Even a tiny rise in bank deposit rates could slow stablecoin growth significantly. According to a recent study by the Bank for International Settlements (BIS), a one basis point increase in bank interest rates reduces the growth in market capitalization of stablecoins by about 3% over ten weeks.

Given that the overall growth is at approximately 15% annually, this decrease would reduce the amount of growth to be approximately 12% annually. USD Coin [USDC] shows greater sensitivity, with growth declining 4.8 percentage points, compared with USDT’s 1.9-point reduction.

This difference highlights USDC’s closer ties to U.S. users and institutions. Moreover, higher bank yields make deposits more attractive relative to stablecoins. Yet, the effect remains specific to stablecoins, as researchers found no significant link with other cryptocurrencies.

@media only screen and (min-width: 0px) and (min-height: 0px) { div[id^="bsa-zone_1774359638628-7_123456"] { min-height: 50px; transition: min-height 0.3s ease; } } @media only screen and (min-width: 640px) and (min-height: 0px) { div[id^="bsa-zone_1774359638628-7_123456"] { min-height: 90px; } }
AD

Therefore, increasing interest rates may slow down the growth of new stable coins but will not eliminate the current supply of stablecoins.

Visa expands USDC payment rails

On the other hand, while bank rates challenge stablecoin demand, Visa’s stablecoin expansion highlights growing real-world payment utility.

For example, Visa Direct currently allows payment of wages or purchases made using USDC-funded cross-border payouts in more than 180 countries. Inyo Global is their first partner.

This feature may provide a method for obtaining additional demand for stablecoins beyond simply trading or using decentralized finance.

It should also allow businesses to draw upon available funds at any time, avoiding reliance on banking hours or correspondent networks.

At present, there are still over $300 billion in outstanding stablecoin capitalization. If Visa continues to expand its service to include more countries and/or additional banks, it appears possible that additional demand for stablecoins may develop.

However, if the rate of adoption is slower than expected, stablecoin holders who do not earn interest on their stablecoins may need to consider alternative forms of stablecoins. Some of these alternative forms of stablecoins are already paying interest on idle money.

USDC payment activity accelerates

Visa’s dollar-based stablecoin settlement volume is already at an annualized run rate of $20 billion. That represents more than a 15-fold increase compared with last year.

That data suggests that stablecoins are shifting from purely speculative holdings to being used for actual payments.

Still, according to DeFiLlama data, USDC total circulating supply stands at $72.6 billion. That said, measuring how much USDC is involved in transactional activity is key to determining whether stablecoins are actually supporting commerce or simply accumulating wealth.

If the amount of USDC used in settlements grows faster than the circulating supply of USDC, it could begin to counteract some of the loss in demand due to increasing deposit rates at banks.

For this trend to continue, merchants and others will need to continue processing multiple transactions using prefunded USDC balances.

Final Summary

  • Stablecoin growth faces pressure as rising bank deposit rates make traditional savings more attractive, slowing market capitalization expansion.

  • USD Coin [USDC] payment adoption could support stablecoin demand as Visa’s settlement volume exceeds a $20 billion annualized run rate.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

U.S. non-farm payrolls surge by 165,000 in October, far exceeding expectations! Unemployment rate unexpectedly drops to 4.1%, December rate hike expectations intensify

In October, US non-farm payrolls increased by 165,000, which is 2.5 times the Wall Street median forecast of 65,000 and represents an exceptionally strong deviation of about 5 standard deviations, exceeding the upper limit of all institutional forecast ranges. The unemployment rate unexpectedly fell from 4.2% to 4.1%, while the market had expected it to remain unchanged; average hourly wages also accelerated year-on-year growth to 3.1%. Meanwhile, the previous two months' non-farm payrolls were revised upwards by a total of 84,000. Following the release of the data, the yield on 2-year US Treasury bonds rose by 7 basis points, and the pricing of the probability of a Fed rate hike in December climbed to 70%.

华尔街见闻•2026/11/06 15:01

AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion

The valuation range discussed by potential investors has been lowered from the previous high of $2 trillion to between $1.2 trillion and $1.3 trillion, and some strategists have even suggested going below $1 trillion to ensure safety. In the face of significant market volatility and financial concerns such as quarterly losses, Anthropic is facing tough decisions, including a discounted valuation, reducing the size of the offering, or postponing the listing.

华尔街见闻•2026/11/06 13:42
AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion

Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight

Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.

华尔街见闻•2026/11/06 13:23